Bibliographies (past 5 years)
- Rondina M, Pendleton R, Wheeler M and Rodgers G. VTE Treatment in Special Patient Populations. Thrombosis Research. 2007; 119: 391-402.
- Pendleton, R. Blood Issues: Anticoagulation Management of Special Populations. Audio-digest. General Surgery. Feb 2007. Volume 54(Issue 03).
- Rondina, MT, Rodgers, GM, Nohavec R, Markewitz BA. The Accuracy of Activated Partial Thromboplastin Times when Drawn Through a Peripherally Inserted Central Catheter. Am J Hematology 2007 Aug; 82(8):738-9
- Schwertz H, Tolley ND, Foulks JM, Denis MM, Rondina MT, Harris EM, Kraiss LW, Zimmerman GA, Weyrich AS. Cdcd2-like Kinase 1 Regulates Tissue Factor Pre-mRNA Splicing in Human Platelets. J Exp Med 2006;203:2433-40.
- Pendleton RC, Wheeler, M and Rodgers G. Argatroban Dosing of Patients With Heparin-Induced Thrombocytopenia and an Elevated Baseline APTT Due to Antiphospholipid Antibody Syndrome- A Single Institution Case Series. Annals of Pharmacotherapy. May 2006; 40:972-976.
- Creekmore F, Pendleton RC, et al. The Incidence and Economic Implications of Heparin Induced Thrombocytopenia when Preventing Venous Thrombosis in Medical Patients. Pharmacotherapy 2006; 26(10): 1438-1445.
- Pendleton RC and Rodgers GM. An Unusual case in the diagnosis and management of acute pulmonary embolism. A J Med 2006; 119(8): 651-653.
- Pendleton, R. Issues in Coagulation: A practical approach to peri-procedural anticoagulation. Audio-digest. General Surgery. Aug 2006.53(15).
- Pendleton, R. Issues in Coagulation: The must knows of heparin-induced thrombocytopenia. Audio-digest. General Surgery. Aug 2006.53(15).
- Rondina MT, Muhlestein JB. Initiation of Statin Therapy for Acute Coronary Syndromes: A Review of the Evidence. Journal of Interventional Cardiology 2005;18(1):55-63
- Stinnett J, Pendleton R, Skordos L, Wheeler M, Rodgers G.. Venous Thromboembolism Prophylaxis in Medically Ill Patients and the Development of Strategies to Improve Prophylaxis Rates. A J Hematology2005; 78:167-17
- Pendleton, R, Wheeler, M and Rodgers G. Venous Thromboembolism Prevention in the Acutely-Ill Medical Patient: A Review of the Literature and Focus on Special Patient Populations. A J Hematology July 2005; 79:229-237.
- Fiessenger et al. For the THRIVE Treatment Study Investigators. A double blind safety and efficacy study of the Oral Direct Thrombin Inhibitor, H376/95 versus standard therapy [Enoxaparin and Warfarin] in patients with Acute Symptomatic Deep venous thrombosis with or without Pulmonary Embolism. JAMA 2005; 293: 681 – 689
- Zebrack JS, Rondina MT. Clinical Study: Achieving National Cholesterol Education Program Goals in Coronary Artery Disease. Prev Cardiol. 2005 Winter;8(1):18-22
